Abstract
BackgroundIn the last years, the “treat to target” strategy revealed the importance of tight control of disease activity in RA patients1. To reach clinical remission or at least low disease...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
